2018 annual financial data
Aptevo Therapeutics 2018 Net margin
Direct answer
Net margin was -232.75%.
Operating income was -51,665,000 USD and net income was -53,689,000 USD.
Operating cash flow was -51,422,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 23,067,000 USD
- Operating income
- -51,665,000 USD
- Net income
- -53,689,000 USD
- Operating cash flow
- -51,422,000 USD